Following Pfizer, a major American pharmaceutical company, applying for approval of the new coronavirus vaccine to the Ministry of Health, Labor and Welfare for the first time in Japan, Minister of Health, Labor and Welfare Tamura immediately confirmed the safety and efficacy and proceeded with the examination with the highest priority. I showed my idea to go.
Pfizer, a major American pharmaceutical company, filed an application for approval from the Ministry of Health, Labor and Welfare for the first time in Japan on the 18th for the use of the new coronavirus vaccine in Japan.
Minister of Health, Labor and Welfare Tamura told reporters on the evening of the 18th, "The content of the application is to inoculate twice every three weeks. Overseas clinical trial data is attached, and domestic clinical trials will be done by February next year. I've heard that additional key data will be submitted. "
After that, he said, "We are instructing the relevant departments to conduct the examination promptly with the highest priority," and expressed the idea of conducting the examination based on the "special approval" system that greatly simplifies the procedure.
He emphasized, "We will thoroughly examine the efficacy and safety, and if approved, we will prepare the inoculation system as soon as possible so that the person who wants it can hit it."
Regarding concerns about side reactions, he said, "I would like to thoroughly analyze reports of side reactions and disseminate information to the public."